Estimating the Burden of Diabetes in Kuwait

Principal Investigators: Dr Zlatko Nikoloski and Professor Fahd Al-Mulla
Duration: October 2018–December 2020

Heart rate graph

Diabetes imposes large economic burden on national health care systems and affects both national economies and individuals and their families. Direct medical costs include resources used to treat the disease (thus included outpatient care, inpatient care, medications, medical devices and long term care) (Seuring et al, 2015). Indirect costs include lost productivity caused by morbidity, disability, and premature mortality. Intangible costs refer to the reduced quality of life for people with diabetes brought about by stress, pain, and anxiety.

Against this background, this project has a three-fold objective: (i) to analyse the link between diabetes and healthcare utilization (both, outpatient and inpatient); (ii) based on (i), to determine the total (direct and indirect) cost of diabetes in Kuwait by providing a static measure of the cost of diabetes; and (iii) to critically evaluate the existing preventive measures (by also doing a comparative analysis with the rest of the Gulf region) aiming at reducing the overall economic burden of diabetes in Kuwait. The preventative measures will then be used in dynamic simulations that will help devise strategies for further reducing the economic burden of diabetes.


Determinants of Diabetes in Kuwait_cover 500x733

Determinants of Diabetes in Kuwait: Evidence from the World Health Survey

Zlatko Nikoloski, August 2020

Download the paper


Principal Investigators

Zlatko Nikoloski

Dr Zlatko Nikoloski

Zlatko is an Assistant Professorial Research Fellow in LSE Health.

Professor Fahd Al-Mulla

Fahd is the Acting Chief Scientific Officer in the Research Division at Dasman Diabetes Institute.

Research Assistant

Kyriopoulos, Ilias

Ilias Kyriopoulos

Ilias is a PhD student in the Department of Social Policy at LSE.